Evidence map›Paper›PMID 32605327›Full record

ArticleMarine drugs2020

Immunomodulatory Effects of a Low-Molecular Weight Polysaccharide from

Yingjuan Liu, Xiaolin Wu, Weihua Jin, Yunliang Guo

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Marine drugs · 2022
    Pooled it
  2. Article
  3. Immune Enhancement of FermentedMolecules (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Regulatory Effects Mediated byFoods (Basel, Switzerland) · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Understanding immune-modulatory efficacy in vitro.Chemico-biological interactions · 2022
    Review
  15. Antitumor effects of polysaccharides fromFrontiers in immunology · 2022
    Article
  16. Article
  17. Review
  18. DietaryFrontiers in nutrition · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yingjuan LiuMedical College, Qingdao University, Qingdao 266071, China.
Xiaolin WuMedical College, Qingdao University, Qingdao 266071, China.
Weihua JinCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China.
Yunliang GuoMedical College, Qingdao University, Qingdao 266071, China.
Qingdao University · CNZhejiang University of Technology · CN

Funding

China Postdoctoral Science Foundation NO. 2018M640611Doctor Innovation Program of Shandong Province NO. 201902036Qingdao Applied Research Program of postdoctoral Researchers NO.2019022Shandong Provincial Natural Science Foundation NO. ZR2019BD026Zhejiang Provincial Natural Science Foundation of China No. LY19D060006
6 · The paper itself

Abstract

The water-soluble polysaccharide EP2, from

Indexed as

AnimalsChlorophytaCyclophosphamideImmunosuppression TherapyImmunosuppressive AgentsMiceMice, Inbred ICRPolysaccharidesRandom AllocationRAW 264.7 CellsCyclophosphamideImmunosuppressive AgentsPolysaccharidescyclophosphamideEnteromorpha proliferaimmunomodulationpolysaccharidesRAW 264.7 cells

Identifiers

PMID32605327
PMCPMC7401259
OpenAlexW3037846088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.